Methods for treatment and prevention of tauopathies and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 31/519 (2006.01) A61K 47/48 (2006.01) A61P 25/28 (2006.01) C12Q 1/00 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2692039

Methods for treating or preventing tauopathies and/or A.beta. amyloidosis by modulating CRF receptor signaling. Ac-cumulation of hyperphosphorlyated tau protein in the CNS may be reduced by administration of CRF-R1 selective antagonists and/or CRF-R2 selective agonists. For example, in some aspects, methods for preventing the onset of Alzheimer's disease by administration of CRF-R1 selective antagonist are provided.

L'invention concerne des procédés pour traiter ou empêcher des tauopathies et/ou amyloïdose d'Ab en modulant la signalisation de récepteur CRF. L'accumulation de protéine tau hyperphosphorylée dans le CNS peut être réduite par l'administration d'antagonistes sélectifs de CRF-R1 et/ou d'agonistes sélectifs de CRF-R2. Par exemple, dans certains aspects, des procédés pour empêcher l'apparition de la maladie d'Alzheimer par l'administration de l'antagoniste sélectif de CRF-R1 sont fournis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treatment and prevention of tauopathies and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treatment and prevention of tauopathies and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment and prevention of tauopathies and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2027036

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.